Among the one-third of adults with epilepsy of unknown etiology, an autoimmune cause appears to be the culprit in at least 20%. This new scoring system may help identify them. Visit us on Facebook.

Cabaletta has been evaluating the CAR-T, called resecabtagene autoleucel or rese-cel , across six so-called RESET studies ...